SCHEMBL6491102

SCHEMBL6491102

CCOC(=O)CCCOc1ccc2nc(C)n(Cc3ccc(N(C)C(=O)OCC)cc3Cl)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 3/20 0.43
PDE3A Q14432 3/20 0.43
P2RY12 Q9H244 1/20 0.43
PPARG P37231 1/20 0.41
PLA2G2A P14555 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
CYSLTR2 Q9NS75 3/20 0.37
CYSLTR1 Q9Y271 3/20 0.37
BRD4 O60885 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MCL1 Q07820 1/20 0.35
F2 P00734 1/20 0.35
F10 P00742 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6491416 0.93 PPARG (0.41) PDE3BPDE3AP2RY12PPARGPLA2G2A
SCHEMBL6498632 0.88 PDE3B (0.48) PDE3BPDE3AP2RY12PPARGPLA2G2A
SCHEMBL6486754 0.88 MCL1 (0.37) PDE3BPDE3AP2RY12PPARGPLA2G2A
SCHEMBL6495068 0.87 PPARG (0.52) PDE3BPDE3AP2RY12PPARGPLA2G2A
SCHEMBL6497461 0.86 PPARG (0.49) PDE3BPDE3AP2RY12PPARGPLA2G2A
SCHEMBL6500673 0.85 PPARG (0.49) PDE3BPDE3AP2RY12PPARGPLA2G2A
SCHEMBL6487701 0.84 PPARG (0.49) PDE3BPDE3AP2RY12PPARGPLA2G2A
SCHEMBL6497679 0.81 MCL1 (0.40) PLA2G2AMCL1DCTPP1
SCHEMBL6490596 0.80 MCL1 (0.38) PDE3BPDE3AP2RY12PPARGPLA2G2A
SCHEMBL6491237 0.80 FFAR1 (0.49) PDE3BPDE3AP2RY12PPARGPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD PDE3B 411/4885PDE3A 733/4885P2RY12 2028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.